MYP_075072
Basic Information
E1P52-1
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
18 amino acids
C89H158N18O23S
Standard
Sequence
VISLTPLLVCVAALLLLE
Physicochemical Analysis
1880.38 Da
4.60
-1.27
-1.50
-0.0704
2.40
0.19
0.71
5.26
232.78
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
626.99
-0.31
22.0
23.0
59.0
131.0
1.0
17.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0289602 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells
125 μM
IC50
RECORD: Rec_0307708 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 NL4-3 | TZM-bl cells
125 μM
IC50
Mammalian: 100 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0365243 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Aurein
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1 NL4-3
125 μM
IC50